Search Orphan Drug Designations and Approvals
-
Generic Name: | nanoparticles containing Zoledronic acid |
---|---|
Date Designated: | 11/29/2016 |
Orphan Designation: | Treatment of Glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Laboratorio Italiano Biochimico Farmaceutico Lisapharma SpA Via Licinio 11 Erba (CO), Lombardia Italy The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-